FPRX

Five Prime Therapeutics, Inc. News Headlines

$22.42
*  
0.50
2.28%
Get FPRX Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FPRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Five Prime To Present At Oppenheimer Conference; Webcast At 3:55 PM ET
12/10/2014 2:55:00 PM - RTT News


CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod
12/5/2014 12:20:00 AM - RTT News


Five Prime Therapeutics To Participate In Piper Jaffray Conference At 12:30PM ET
12/3/2014 11:30:00 AM - RTT News


Five Prime Therapeutics Up on Deal with Bristol-Myers - Analyst Blog
11/26/2014 4:30:00 PM - Zacks.com


Five Prime Therapeutics, Inc. (FPRX) in Focus: Stock Soars 31.4% - Tale of the Tape
11/25/2014 9:18:00 AM - Zacks.com


FPRX Gets High Five, CLRX Put On Notice, RNA Snapped Up, Natesto Changes Hands
11/25/2014 12:07:00 AM - RTT News


Monday Sector Leaders: Music & Electronics Stores, Drugs
11/24/2014 1:57:14 PM - BNK Invest


Five Prime Therapeutics (FPRX) Is Up Sharply After BMY Collaboration
11/24/2014 10:03:00 AM - RTT News


Bristol-Myers, Five Prime to Collaborate on Immunotherapy
11/24/2014 9:40:00 AM - Dow Jones Business News


Bristol-Myers, Five Prime Therapeutics Enter Into Clinical Collaboration Deal
11/24/2014 9:20:00 AM - RTT News


Five Prime Therapeutics Expands Collaboration With GSK
10/24/2014 1:03:00 AM - RTT News


Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 5:00:00 PM - Zacks.com


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
8/12/2014 7:51:00 AM - Zacks.com


Bristol-Myers & CytomX Therapeutics Join Forces - Analyst Blog
5/28/2014 10:50:00 AM - Zacks.com


Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
4/23/2014 4:30:01 PM - Zacks.com


Should Five Prime Therapeutics (FPRX) Be On Your Radar Now? - Tale of the Tape
4/10/2014 7:53:01 AM - Zacks.com


Earnings Estimates Moving Higher for Five Prime (FPRX): Time to Buy? - Tale of the Tape
4/4/2014 7:47:01 AM - Zacks.com


Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 10:00:01 AM - Zacks.com


Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 11:00:01 AM - Zacks.com


Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 8:18:01 AM - Zacks.com


Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
10/30/2013 2:47:00 PM - Seeking Alpha


Five Prime Therapeutics - Another Risky Cancer Research Public Offering
9/23/2013 7:05:00 AM - Seeking Alpha


Five Prime Therapeutics prices IPO at $13, within the range
9/17/2013 7:08:06 PM - Renaissance Capital


IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha